Radoslav Jovanovic, MD
Maternal & Fetal Medicine · New York, NYNPI 1851399521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 37.3% of the total. Reporting peaked in 2019 at $814 and has fallen 98.3% since, to $14 in 2022. Among maternal & fetal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Therapeuticsmd, Inc.$338
- Duchesnay USA Incorporated$172
- Millicent US Inc$126
- Avion Pharmaceuticals$82
- Evofem Biosciences, Inc.$73
- plus $528 from 16 others
What the payments were for
- Food & beverage$2,08099%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $786 |
| Therapeuticsmd, Inc. | 22 | $338 |
| Duchesnay USA Incorporated | 4 | $172 |
| Millicent US Inc | 7 | $126 |
| Avion Pharmaceuticals | 5 | $82 |
| Evofem Biosciences, Inc. | 4 | $73 |
| Vertical Pharmaceuticals, LLC | 3 | $62 |
| Eisai Inc. | 4 | $60 |
| Merz North America, Inc. | 2 | $52 |
| Lupin Inc. | 3 | $49 |
| Exeltis, USA Inc. | 3 | $46 |
| Mission Pharmacal Company | 3 | $44 |
| Roche Diagnostics Corporation | 1 | $26 |
| AMAG Pharmaceuticals, Inc. | 1 | $25 |
| Myovant Sciences Inc. | 1 | $25 |
| Biogen | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Merck | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,105 in reported general payments places this provider in the 90th percentile of 185 maternal & fetal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other maternal & fetal medicine in New York
- Heather LipkindNew York$60K
- Mary DaltonNew York$58K
- Eran BornsteinNew York$56K
- Ilan TimorNew York$36K
- Lisa NathanNew York$32K
- Kevin JovanovicNew York$10K
- Russell MillerNew York$8K
- Alexander FriedmanNew York$3K
- Daniel RoshanNew York$2K
- Richard BerkowitzNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.